RNA aptamers targeting cancer stem cell marker CD133

► Cancer stem cells (CSCs) are thought to be responsible for post-therapy relapse of cancer. ► AC133, a CSC marker, represents a unique target for the treatment of various tumour types. ► Aptamers generated against the CD133 protein bind to two separate epitopes. ► These aptamers represent the ideal molecule for use as targeted theranostics.